Unlike widely covered large caps, CTM does not have a meaningful, multi-analyst price-target consensus. Public data providers show essentially one covering firm, Maxim Group, and the reported figure is not consistent: TipRanks lists a $3.50 target (reiterated in May 2026), MarketBeat-style aggregators show figures near $3.00, and Yahoo Finance's one-year target estimate reads $2.00. With a single, conflicting estimate, an "average analyst price target" would be misleading, so this article does not present one.
Instead, the $1.00 objective reflects a realistic technical and psychological milestone that has been visible in public market discussion: the round-number $1.00 level sits well inside the stock's trailing 52-week range of $0.48 to $1.36, a zone CTM traded through earlier in the year before its recent slide toward its 52-week low. This is a fallback price objective rooted in market structure and recent trading history, not a formal analyst consensus or a forecast. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
As of late October 2026, Castellum shares traded around $0.49, near the bottom of a 52-week range that stretches up to $1.36. Reaching $1.00 would imply upside of roughly 100% — by any measure a very large move, and one that would still leave the stock below its 52-week high.
The path toward such a level would likely depend on fundamentals, not momentum alone. The company has reported accelerating top-line growth: first-quarter 2026 revenue rose about 23% to $14.3 million, and first-half 2026 revenue increased 10% to $28.2 million. Management ended the second quarter with a record total backlog of roughly $271.7 million and a debt-free balance sheet holding about $16.9 million in cash. The company has characterized 2026 as an expected record year for revenue. Still, the stock remains unprofitable, with negative EPS on a trailing basis, and its roughly $46 million market capitalization keeps it in the high-volatility micro-cap category.
The stock is testing its 52-week low near $0.48, which now acts as the key support level. Overhead, the 50-day moving average around $0.60 and the 200-day moving average near $0.72 form the first resistance zones; a sustained advance would then need to clear the $1.00 psychological level before the 52-week high of $1.36 comes into view. The wide gap between the current price and these moving averages illustrates how far the stock has fallen and how much technical repair a move toward $1.00 would require. From what I see, the patterns here warrant close attention to volume on any rebound.
Analyst price targets typically reflect a roughly 12-month research horizon, though with only one inconsistent estimate here, no meaningful consensus horizon can be inferred. Investors should watch the next quarterly earnings release and conference call for updates on backlog conversion, margins, and any progress toward sustained profitability; new contract awards or modifications; any further capital raises or dilution; and developments in the CMMC and federal-cybersecurity landscape that could affect demand. Technical observers should monitor whether the $0.48 support level holds and whether the stock can reclaim its 50-day and 200-day moving averages.
The question of whether Castellum can reach $1.00 is best understood as a question about whether the stock can reclaim a round-number level it traded through earlier in its 52-week range — not whether it will meet a formal analyst consensus, because no reliable consensus exists. The move would require roughly a 100% advance from about $0.49, a very large climb for a micro-cap with persistent losses and thin coverage. The bull case rests on accelerating revenue, a record backlog, a debt-free balance sheet, and strong positioning in federal cybersecurity and electronic warfare. The bear case rests on continued unprofitability, dilution risk, and the technical overhead of moving averages and prior highs. Investors should monitor earnings, backlog conversion, contract wins, and any new capital raises rather than treat $1.00 as an assured destination.
In my own workflow, Tickeron's AI Daily Buy/Sell Signals have become a useful reference for monitoring high-volatility names like this one. The system uses artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on evolving market conditions and technical factors. For micro-caps with sharp swings, it offers a structured way to track momentum shifts without constant manual chart reviews. I find it particularly helpful for spotting when sentiment or volume patterns start to change.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
It is expected that a price bounce should occur soon.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +5.39% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTM advanced for three days, in 191 of 229 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
CTM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CTM as a result. In 77 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The Moving Average Convergence Divergence Histogram (MACD) for CTM turned negative on October 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 39 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for CTM entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.281) is normal, around the industry mean (2.821). P/E Ratio (-16.167) is within average values for comparable stocks, (17.971). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.172) among similar stocks. P/S Ratio (1.076) is also within normal values, averaging (139.965).
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. CTM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InformationTechnologyServices